Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin

BACKGROUND: Breast cancer often metastasizes into bone and leads to osteolytic lesions. The underlying mechanisms, however, are complex and not fully understood. Syndecan-1 is a proteoglycan that has various functions relevant for tumor progression including cell–cell communication and cell–matrix i...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Bone Oncol
Huvudupphovsmän: Benad-Mehner, Peggy, Thiele, Stefanie, Rachner, Tilman D., Göbel, Andy, Rauner, Martina, Hofbauer, Lorenz C.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Elsevier 2013
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4723417/
https://ncbi.nlm.nih.gov/pubmed/26909290
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2013.11.001
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk